Outlook Therapeutics
Total Raised
$51.85MInvestors Count
11Deal Terms
2Funding, Valuation & Revenue
7 Fundings
Outlook Therapeutics has raised $51.85M over 7 rounds.
Outlook Therapeutics's latest funding round was a PIPE - II for $16M on May 26, 2020.
Outlook Therapeutics's valuation in May 2016 was $136.82M.
Outlook Therapeutics's 2020 revenue was $5.85M. Outlook Therapeutics's most recent revenue is from 2020.
Sign up for a free demo to see revenue data from 2020 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
5/26/2020 | PIPE - II | $16M | 2 | |||
1/4/2019 | PIPE | $5.85M FY 2020 | ||||
5/13/2016 | IPO | $136.82M | ||||
12/23/2015 | Series A - III | |||||
9/29/2015 | Series A - II |
Date | 5/26/2020 | 1/4/2019 | 5/13/2016 | 12/23/2015 | 9/29/2015 |
|---|---|---|---|---|---|
Round | PIPE - II | PIPE | IPO | Series A - III | Series A - II |
Amount | $16M | ||||
Investors | |||||
Valuation | $136.82M | ||||
Revenue | $5.85M FY 2020 | ||||
Sources | 2 |
Outlook Therapeutics Deal Terms
2 Deal Terms
Outlook Therapeutics's deal structure is available for 2 funding rounds, including their IPO from May 13, 2016.
Round | IPO | Series A |
|---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IPO | |||||||||||||||
Series A |
Outlook Therapeutics Investors
11 Investors
Outlook Therapeutics has 11 investors. Syntone Ventures invested in Outlook Therapeutics's PIPE - II funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
5/26/2020 | 5/26/2020 | 1 PIPE - II | Venture Capital | North Carolina | ||
1/4/2019 | 1/4/2019 | 1 PIPE | Corporation | Singapore | ||
9/29/2015 | 9/29/2015 | 1 Series A - II | Hedge Fund | |||
Hedge Fund | New York | |||||
Asset/Investment Management | Massachusetts |
First funding | 5/26/2020 | 1/4/2019 | 9/29/2015 | ||
|---|---|---|---|---|---|
Last Funding | 5/26/2020 | 1/4/2019 | 9/29/2015 | ||
Investor | |||||
Rounds | 1 PIPE - II | 1 PIPE | 1 Series A - II | ||
Board Seats | |||||
Type | Venture Capital | Corporation | Hedge Fund | Hedge Fund | Asset/Investment Management |
Location | North Carolina | Singapore | New York | Massachusetts |
Loading...